Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15900595rdf:typepubmed:Citationlld:pubmed
pubmed-article:15900595lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:15900595lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:15900595lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:15900595lifeskim:mentionsumls-concept:C0032790lld:lifeskim
pubmed-article:15900595lifeskim:mentionsumls-concept:C0085533lld:lifeskim
pubmed-article:15900595lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:15900595lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:15900595pubmed:issue3lld:pubmed
pubmed-article:15900595pubmed:dateCreated2005-9-21lld:pubmed
pubmed-article:15900595pubmed:abstractTextCisplatin-based (CDDP-based) adjuvant chemotherapy of non-small cell lung cancer (NSCLC) was reported to yield 5-15% improvement in 5-year survival compared to complete resection alone. The importance of information concerning preselection of good responders has become increasingly evident. The purpose of our study is the establishment of a preselection of good responders for CDDP-based adjuvant chemotherapy. We investigated protein expressions comparing intensity between parent strains (H69 and PC14 lung cancer cultured cells) and resistant strains against CDDP using 2-dimensional polyacrylamide gel electrophoresis (2-DE). Immunohistochemically, we evaluated the relationship between protein expression associated with CDDP-resistance and the clinical effects of platinum-based postoperative adjuvant chemotherapy using 126 surgically-resected NCLC materials. We detected 2 kinds of polypeptides that changed expression levels on 2-DE gels. The analyses of the amino acid sequence showed that these polypeptides were reticulocalbin (RCN) and glutathione-S-transferase-pi (GST-pi). The 2-DE analysis showed decreased expression in RCN and overexpression in GST-pi with the acquisition of CDDP-drug resistance. RCN-transfectant of H69 CDDP-resistant strain showed intermediate sensitivity between the parent strain and the CDDP-resistant strain. RCN-positive cases showed a statistically significant better disease-free survival only in the cases receiving postoperative platinum-based adjuvant chemotherapy after curative resection (p = 0.007). In addition, cases that were both RCN-positive and GST-pi-negative showed a statistically significantly better outcome (p = 0.0150). In the cases without postoperative adjuvant chemotherapy no relationship between the outcome and these expressions was seen. The evaluation of RCN and GST-pi might provide valuable information concerning postoperatively therapeutic strategy from the standpoint of individualized postoperative therapy.lld:pubmed
pubmed-article:15900595pubmed:languageenglld:pubmed
pubmed-article:15900595pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:citationSubsetIMlld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15900595pubmed:statusMEDLINElld:pubmed
pubmed-article:15900595pubmed:monthNovlld:pubmed
pubmed-article:15900595pubmed:issn0020-7136lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:HiranoTakashi...lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:IkedaNorihiko...lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:KatoHarubumiHlld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:MaedaMasahiro...lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:TsuboiMasahir...lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:KatoYasufumiYlld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:MaedaJunichiJlld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:OhiraTatsuoTlld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:AkimotoShingo...lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:NakamuraMihoMlld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:GongYunboYlld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:YashimaKoichi...lld:pubmed
pubmed-article:15900595pubmed:authorpubmed-author:ShouYanningYlld:pubmed
pubmed-article:15900595pubmed:issnTypePrintlld:pubmed
pubmed-article:15900595pubmed:day10lld:pubmed
pubmed-article:15900595pubmed:volume117lld:pubmed
pubmed-article:15900595pubmed:ownerNLMlld:pubmed
pubmed-article:15900595pubmed:authorsCompleteYlld:pubmed
pubmed-article:15900595pubmed:pagination460-8lld:pubmed
pubmed-article:15900595pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:meshHeadingpubmed-meshheading:15900595...lld:pubmed
pubmed-article:15900595pubmed:year2005lld:pubmed
pubmed-article:15900595pubmed:articleTitleIdentification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker.lld:pubmed
pubmed-article:15900595pubmed:affiliationDepartment of Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan. thirano@tokyo-med.ac.jplld:pubmed
pubmed-article:15900595pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15900595pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2950entrezgene:pubmedpubmed-article:15900595lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15900595lld:entrezgene
lhgdn:association:57993lhgdn:found_inpubmed-article:15900595lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15900595lld:pubmed